Department of Urologic Surgery Archives
Mar. 21, 2017—Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).
Sep. 22, 2016—Vanderbilt University Medical Center is the world’s first site to treat a patient in the TULSA-PRO Ablation Clinical Trial (TACT), which employs an emerging therapy that uses MRI guidance and robotically driven therapeutic ultrasound to obtain precise prostate cancer tissue ablation.
Jun. 28, 2016—John and Valerie Longoria breathed a sigh of relief when the team lead by John C. Pope IV, M.D., professor of Urologic Surgery and Pediatrics, told them a minor procedure on their 8-month-old son Maverick had been successful, and they could soon take their son home to Oak Grove, Kentucky. But then, things quickly changed.
Mar. 10, 2016—The Society for Urodynamics and Female Urology (SUFU), the premier specialty society for female pelvic medicine and reconstructive surgery, is awarding Vanderbilt’s Roger Dmochowski, M.D., professor of Urologic Surgery, with its SUFU Lifetime Achievement Award.
Dec. 10, 2015—The Society of Urologic Oncology (SUO) is recognizing Joseph Smith Jr., M.D., professor of Urologic Surgery, with the Huggins Medal, its highest honor, for his lifetime contributions to the progress in treatment for patients with genitourinary neoplasms, which are tumors or cancer of the reproductive organs and the urinary system.
Nov. 5, 2015—Beginning this week, Vanderbilt men will have a good excuse to ignore their razors and let their facial hair grow. November has been dubbed “Movember,” a time when men are encouraged to grow a moustache to raise funds and awareness for prostate cancer.
May. 28, 2015—As health care organizations implement new strategies to improve quality and reduce costs, a physician researcher at VUMC is setting out to identify whether there could be unintended effects.
Apr. 16, 2015—A new study led by Vanderbilt University investigators found that patients being treated with statins at the time of surgery for kidney cancer, also known as renal cell carcinoma, had improved overall survival and disease-specific survival.